Industry Resources


Fragmented cardiometabolic care increases costs & worsens outcomes. Learn why integrated solutions are essential for lowering healthcare spend and improving member health.
Learn more
Trending: Weight Management Solutions
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
.png)
.png)
Driven to Care: Ashley Longseth, Director, Business Operations
November 25, 2024
/
min
Healthy Lifestyle
Individuals
LARK
Wellness
Insights


Driven to Care: Natalie Stein, Head of Clinical Product and Research
November 15, 2024
/
min
Healthy Lifestyle
Individuals
LARK
Insights


2024 HLTH Recap: GLP-1s Going Under-Covered Panel
November 5, 2024
/
min
Brokers
Clinical
Employers
GLP-1
Health Plans


Key Insights From The "GLP-1s Going Under-Covered" Panel: 2024 HLTH Recap
November 5, 2024
/
min
Clinical
Employers
GLP-1
Health Plans
Healthcare


GLP-1 Holistic Care, Cardiometabolic and Cost Containment Best Practices: 2024 AHIP Digital Recap
October 9, 2024
/
min
GLP-1
Employers
Health Plans
Healthcare
Wellness


Lark’s Coach+ and the Evolution of Food Logging & Meal Planning
September 4, 2024
/
min
Foods
News
Nutrition
Meal Plan
Technology
.jpg)
.jpg)
Healthcare’s Year Ahead: What’s Already Happening in 2024
March 1, 2024
/
min
Clinical
Employers
GLP-1
Health Plans
Healthcare


White Paper: A Comprehensive Examination of the Evidence Supporting Lark’s Digital Health Programs
February 5, 2024
/
10
min
This white paper demonstrates Lark’s effectiveness and underscores Lark's contribution to reshaping the future of healthcare.
LARK
Health Plans
Healthcare
Clinical
Employers


Exploring Weight Management and Obesity Strategies at the California Association of Health Plans Event
December 11, 2023
/
min
The 2023 California Association of Health Plans conference was an innovative and collaborative experience for the California healthcare industry.
GLP-1
Medication
Weight Loss


Employers Must Brace for 2024 GLP-1 Cost Conundrum
December 5, 2023
/
min
The surge in employee demand for GLP-1 medications has presented organizations with an ongoing dilemma of coverage. And this will be exacerbated with the looming arrival of oral GLP-1s3 that will like
Diabetes
Employers
GLP-1
Technology






